Dr. Elaine S Pappas is a pharmacist who is specialized in Pharmacotherapy in Seattle, Washington. Patients can reach her at 206 3rd Ave S, Pioneer Square Clinic Pharmacy, Seattle or contact her on 206-521-1750. Active license number of Dr. Elaine S Pappas is PH00018419 for Pharmacotherapy in Washington. Dr. Elaine S Pappas is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Elaine S Pappas speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Elaine S Pappas are as mentioned below.
NPI Number:
1457329013
NPI Enumeration Date:
09 Mar, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Elaine S Pappas are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PH00018419
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
13317 1st Ave Ne, Seattle, Washington
Zip:
98125-3006
Phone Number:
206-440-1194
Fax Number:
206-521-1754
Patients can reach Dr. Elaine S Pappas at 206 3rd Ave S, Pioneer Square Clinic Pharmacy, Seattle, Washington or can call on phone at 206-521-1750.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.